Search by Drug Name or NDC

    NDC 00574-0520-04 ACTIDOSE 208 mg/mL Details

    ACTIDOSE 208 mg/mL

    ACTIDOSE is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by Padagis US LLC. The primary component is ACTIVATED CHARCOAL.

    Product Information

    NDC 00574-0520
    Product ID 0574-0520_25f1d299-8fda-4342-93e0-8965c9dd506c
    Associated GPIs 93000010200900
    GCN Sequence Number 057761
    GCN Sequence Number Description charcoal/sorbitol solution ORAL SUSP 25 G/120ML ORAL
    HIC3 C8E
    HIC3 Description ANTIDOTES,MISCELLANEOUS
    GCN 22989
    HICL Sequence Number 001116
    HICL Sequence Number Description ACTIVATED CHARCOAL/SORBITOL SOLUTION
    Brand/Generic Brand
    Proprietary Name ACTIDOSE
    Proprietary Name Suffix n/a
    Non-Proprietary Name activated charcoal
    Product Type HUMAN OTC DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 208
    Active Ingredient Units mg/mL
    Substance Name ACTIVATED CHARCOAL
    Labeler Name Padagis US LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part357
    Listing Certified Through 2024-12-31

    Package

    NDC 00574-0520-04 (00574052004)

    NDC Package Code 0574-0520-04
    Billing NDC 00574052004
    Package 120 mL in 1 BOTTLE (0574-0520-04)
    Marketing Start Date 2020-12-05
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 76e4fe6a-afd4-4f68-b12d-0b094f750615 Details

    Revised: 12/2021